BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33933845)

  • 21. Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype.
    Hellgren K; Di Giuseppe D; Smedby KE; Sundström C; Askling J; Baecklund E;
    Rheumatology (Oxford); 2021 Feb; 60(2):809-819. PubMed ID: 32810256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Mercer LK; Lunt M; Low AL; Dixon WG; Watson KD; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2015 Jun; 74(6):1087-93. PubMed ID: 24685910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.
    Ljung L; Askling J; Rantapää-Dahlqvist S; Jacobsson L;
    Arthritis Res Ther; 2014 Jun; 16(3):R127. PubMed ID: 24941916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.
    Lee H
    Yonsei Med J; 2019 Feb; 60(2):223-229. PubMed ID: 30666845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee.
    Matteson EL; Hickey AR; Maguire L; Tilson HH; Urowitz MB
    J Rheumatol; 1991 Jun; 18(6):809-14. PubMed ID: 1895261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Biologic Therapy in Racial Minorities With Rheumatoid Arthritis From 2 US Health Care Systems.
    Kerr GS; Swearingen C; Mikuls TR; Yazici Y
    J Clin Rheumatol; 2017 Jan; 23(1):12-18. PubMed ID: 28002151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
    Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
    Curtis JR; Baddley JW; Yang S; Patkar N; Chen L; Delzell E; Mikuls TR; Saag KG; Singh J; Safford M; Cannon GW
    Arthritis Res Ther; 2011; 13(5):R155. PubMed ID: 21933396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
    England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DRB1 Haplotypes, Shared Epitope, and Disease Outcomes in US Veterans with Rheumatoid Arthritis.
    Zhao M; Mauer L; Sayles H; Cannon GW; Reimold A; Kerr GS; Baker JF; Thiele GM; England BR; Mikuls TR
    J Rheumatol; 2019 Jul; 46(7):685-693. PubMed ID: 30824656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
    Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
    Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
    Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
    J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
    Zhang J; Xie F; Yun H; Chen L; Muntner P; Levitan EB; Safford MM; Kent ST; Osterman MT; Lewis JD; Saag K; Singh JA; Curtis JR
    Ann Rheum Dis; 2016 Oct; 75(10):1813-8. PubMed ID: 26792814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased mortality of incident rheumatoid arthritis versus matched non-RA control subjects: a community-based long-term prospective cohort study.
    Masi AT; Rehman AA; Jorgenson LC; Aldag JC
    Clin Exp Rheumatol; 2017; 35(2):277-287. PubMed ID: 27782866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate.
    Rathbun AM; England BR; Mikuls TR; Ryan AS; Barton JL; Shardell MD; Hochberg MC
    J Rheumatol; 2021 Jun; 48(6):813-820. PubMed ID: 33191277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
    Wadström H; Frisell T; Askling J;
    JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
    Dixon WG; Watson KD; Lunt M; Mercer LK; Hyrich KL; Symmons DP; ;
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):755-63. PubMed ID: 20535785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of cancer associated with the treatment of rheumatoid arthritis.
    Beauparlant P; Papp K; Haraoui B
    Semin Arthritis Rheum; 1999 Dec; 29(3):148-58. PubMed ID: 10622679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.
    Mikuls TR; Fay BT; Michaud K; Sayles H; Thiele GM; Caplan L; Johnson D; Richards JS; Kerr GS; Cannon GW; Reimold A
    Rheumatology (Oxford); 2011 Jan; 50(1):101-9. PubMed ID: 20659916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.